TP53 and cancer: Clinical investigations have increasingly demonstrated that the specific expression profiles of p53 isoforms correlate with tumorigenesis, treatment efficacy, and prognostic outcomes, with isoform distribution exhibiting variability across different cancer types, underscoring its intricate role in oncogenesis [129].